Jingbo Ma
Impact in
-
- Nanoparticle-Based Drug Delivery
-
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
Papers in
-
- Extracellular vesicles in disease 4
- RNA modifications and cancer 2
-
- Nanoplatforms for cancer theranostics 11
- Co-authors
- Zhijie Li (17 shared papers)Jigang Wang (19 shared papers)Chunjin Fu (9 shared papers)Haitao Yuan (10 shared papers)Jianmin Shen (3 shared papers)Keqiang Liu (6 shared papers)Chengchao Xu (5 shared papers)Zhifen Li (8 shared papers)
In The Last Decade
Jingbo Ma
31 papers receiving 521 citations
Peers
Comparison fields: 5 of 87
- Biomaterials 76
- Biomedical Engineering 244
- Cancer Research 76
- Molecular Biology 196
- Immunology 60
Countries citing papers authored by Jingbo Ma
This map shows the geographic impact of Jingbo Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingbo Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingbo Ma more than expected).
Fields of papers citing papers by Jingbo Ma
This network shows the impact of papers produced by Jingbo Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingbo Ma. The network helps show where Jingbo Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Jingbo Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 72 | |
| 2 | 2023 | 39 | |
| 3 | 2018 | 37 | |
| 4 | 2023 | 35 | |
| 5 | 2023 | 31 | |
| 6 | 2019 | 31 | |
| 7 | 2022 | 30 | |
| 8 | 2022 | 27 | |
| 9 | 2021 | 20 | |
| 10 | 2024 | 20 | |
| 11 | 2024 | 20 | |
| 12 | 2020 | 18 | |
| 13 | 2024 | 18 | |
| 14 | 2020 | 18 | |
| 15 | 2016 | 16 | |
| 16 | 2024 | 15 | |
| 17 | 2024 | 15 | |
| 18 | 2020 | 13 | |
| 19 | 2024 | 8 | |
| 20 | 2023 | 6 |
About Jingbo Ma
Jingbo Ma is a scholar working on Molecular Biology, Biomedical Engineering, Immunology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 34 papers that have together received 526 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (11 papers), Advanced Nanomaterials in Catalysis (4 papers), Extracellular vesicles in disease (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Cancer Research and Treatments (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Click Chemistry and Applications (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Biomaterials (76 citations), Biomedical Engineering (244 citations), Cancer Research (76 citations), Molecular Biology (196 citations) and Immunology (60 citations). Jingbo Ma has collaborated with scholars based in China, Australia and Singapore. Frequent co-authors include Zhijie Li, Jigang Wang, Chunjin Fu, Haitao Yuan, Jianmin Shen, Keqiang Liu, Chengchao Xu, Zhifen Li, Jing Chen and Lingyun Dai. Their work appears in journals such as ACS Materials Letters, Acta Pharmaceutica Sinica B, Technology in Cancer Research & Treatment, Bioorganic & Medicinal Chemistry Letters and OncoTargets and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.